Opiant Pharmaceuticals, Inc.
(NASDAQ : OPNT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.01%88.451.3%$921.54m
AMGNAmgen Inc.
0.15%191.531.2%$568.10m
ONCESpark Therapeutics, Inc.
0.18%113.7911.2%$468.71m
GILDGilead Sciences, Inc.
-0.47%65.320.9%$448.73m
BIIBBiogen Inc.
-1.09%326.281.3%$356.55m
BPTHBio-Path Holdings, Inc.
-5.61%27.75190.1%$311.15m
REGNRegeneron Pharmaceuticals, Inc.
-1.22%409.432.6%$285.51m
ILMNIllumina, Inc.
-1.43%305.413.5%$272.22m
VRTXVertex Pharmaceuticals Incorporated
-0.29%187.541.9%$243.52m
SRPTSarepta Therapeutics, Inc.
-0.13%128.2015.4%$216.22m
EXASExact Sciences Corporation
-3.77%91.6125.3%$192.26m
ALXNAlexion Pharmaceuticals, Inc.
-1.12%134.572.0%$180.51m
AAgilent Technologies, Inc.
-0.72%80.521.6%$154.57m
BMRNBioMarin Pharmaceutical Inc.
-0.73%93.844.3%$99.92m
IONSIonis Pharmaceuticals, Inc.
-0.28%78.328.3%$99.66m

Company Profile

Opiant Pharmaceuticals, Inc. is a biopharmaceutical company, which develops pharmaceutical solutions for common addictions and related disorders. The company focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.